4.1 Article

Fast and reproducible chemical synthesis of zearalenone-14-β,D-glucuronide

Journal

WORLD MYCOTOXIN JOURNAL
Volume 5, Issue 3, Pages 289-296

Publisher

WAGENINGEN ACADEMIC PUBLISHERS
DOI: 10.3920/WMJ2012.1404

Keywords

mycotoxin conjugate; biomarker; synthesis; phase II metabolite; glucuronidation; ZEA-14-GlcA

Funding

  1. Austrian Science Fund (FWF) [L255-B11]
  2. EC [KBBE-2007-22269-2 MYCORED]
  3. Federal Ministry of Economy, Family and Youth
  4. National Foundation for Research, Technology and Development
  5. graduate school program Applied Bioscience Technology of the Vienna University of Technology
  6. University of Natural Resources and Life Sciences Vienna

Ask authors/readers for more resources

The Fusarium mycotoxin zearalenone (ZEA) is mainly converted to the conjugate zearalenone-14-beta,D-glucuronide (ZEA-14-GlcA) during phase II detoxification in humans and animals. This metabolite - previously described as zearalenone-4-O-beta, D-glucuronide - is excreted via urine and could therefore serve as possible biomarker for ZEA exposure to estimate its intake. Direct determination of this substance is limited by the availability of a reference substance. So far, only the production of small amounts by enzymatic synthesis has been described. In this work, a fast and reproducible protocol for the chemical synthesis of ZEA-14-GlcA was developed, using substituted beta-resorcylic acid esters as mycotoxin mimics and different glucuronyl donors for optimising the glycosylation (Konigs-Knorr, trifluoroacetimidate method) and the deprotection step. This cost-effective procedure should be easily reproducible in other labs using standard equipment and common reagents.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available